ENDRA Life Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
ENDRA Life Sciences Inc. (NDRA), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on June 21, 2021. The filing reports the entry into a new material definitive agreement regarding equity financing.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or margin data. The primary financial metric disclosed is the authorization of a potential capital raise of up to $20,000,000 in aggregate gross proceeds through the sale of common stock.
Material Changes
- New ATM Agreement: On June 21, 2021, the Company entered into an At-The-Market (ATM) Issuance Sales Agreement with Ascendiant Capital Markets, LLC.
- Termination of Prior Agreement: The Company simultaneously terminated its previous ATM agreement with Ascendiant dated February 19, 2021.
- Commission Structure: The Company agreed to pay Ascendiant a commission of up to 3.0% of the aggregate gross proceeds from shares sold.
Outlook, Risks, and Management Commentary
The Company has no obligation to sell any shares under the new agreement and retains the right to suspend offers or terminate the agreement at any time. The agreement will terminate upon the earlier of the sale of all authorized shares, mutual termination, or the two-year anniversary of the agreement date (June 21, 2023). The filing includes standard legal disclaimers stating it does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Investor Verification Checklist
- Verify the current market price of NDRA common stock to assess potential dilution from future ATM sales.
- Review the shelf registration statement (File No. 333-254711) for detailed terms of the securities being offered.
- Monitor future filings for actual sales volumes and proceeds generated under the new ATM agreement.
- Check the Company's latest 10-K or 10-Q for current cash position and liquidity needs driving this financing facility.